Moreover, SAP (and/or C1q) binding to amyloid modulates inflammation and tissue damage in multiple diseases, including cardiovascular, Alzheimer’s disease, systemic amyloidosis and systemic candidiasis [52,53,54,55]. This evidence concerns the gene APCS and Alzheimer disease.